165 related articles for article (PubMed ID: 30406337)
1. New generation cancer therapy: right direction for sure with some uncertainty.
Ueno Y
Hepatol Int; 2019 Jan; 13(1):22-24. PubMed ID: 30406337
[No Abstract] [Full Text] [Related]
2. Immunotherapy of hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):345-53. PubMed ID: 20528121
[TBL] [Abstract][Full Text] [Related]
3. T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma.
Fisicaro P; Boni C
Cells; 2022 Jan; 11(2):. PubMed ID: 35053296
[TBL] [Abstract][Full Text] [Related]
4. Immune responses in hepatocellular carcinoma.
Korangy F; Höchst B; Manns MP; Greten TF
Dig Dis; 2010; 28(1):150-4. PubMed ID: 20460904
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations.
Xie Y; Xiang Y; Sheng J; Zhang D; Yao X; Yang Y; Zhang X
J Immunol Res; 2018; 2018():8740976. PubMed ID: 29785403
[TBL] [Abstract][Full Text] [Related]
6. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Wang X; Wang Q
Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
Harding JJ; El Dika I; Abou-Alfa GK
Cancer; 2016 Feb; 122(3):367-77. PubMed ID: 26540029
[TBL] [Abstract][Full Text] [Related]
8. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
9. T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.
Ma W; Chen X; Yuan Y
Immunotherapy; 2017 Jun; 9(7):523-525. PubMed ID: 28595519
[No Abstract] [Full Text] [Related]
10. Immunotherapy for hepatocellular carcinoma.
Li S; Yang F; Ren X
Drug Discov Ther; 2015 Oct; 9(5):363-71. PubMed ID: 26632545
[TBL] [Abstract][Full Text] [Related]
11. Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer.
Shetty S; Lujambio A; Tacke F
Front Immunol; 2021; 12():707329. PubMed ID: 34149741
[No Abstract] [Full Text] [Related]
12. [Immune therapy against hepatocellular carcinoma using gene-modified tumor cells].
Miyagi T; Tatsumi T; Hayashi N
Nihon Rinsho; 2001 Oct; 59 Suppl 6():688-92. PubMed ID: 11762038
[No Abstract] [Full Text] [Related]
13. Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.
Zerbini A; Pilli M; Penna A; Pelosi G; Schianchi C; Molinari A; Schivazappa S; Zibera C; Fagnoni FF; Ferrari C; Missale G
Cancer Res; 2006 Jan; 66(2):1139-46. PubMed ID: 16424051
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
Liu P; Chen L; Zhang H
J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy.
Schmidt N; Neumann-Haefelin C; Thimme R
Dig Dis; 2012; 30(5):483-91. PubMed ID: 23108304
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy for hepatocellular carcinoma using dendritic cells].
Homma S; Toda G; Ohno T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():693-8. PubMed ID: 11762039
[No Abstract] [Full Text] [Related]
18. [Immunotherapy of hepatocellular carcinoma].
Geissler M; Mohr L; Blum HE
Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1464-6. PubMed ID: 11753738
[No Abstract] [Full Text] [Related]
19. Adoptive T-cell therapy to treat liver cancer: is the liver microenvironment key?
Willimsky G; Protzer U; Knolle P; Heikenwalder M
Oncotarget; 2013 Aug; 4(8):1117-8. PubMed ID: 23907631
[No Abstract] [Full Text] [Related]
20. Targeting Neoantigens in Hepatocellular Carcinoma for Immunotherapy: A Futile Strategy?
Lu L; Jiang J; Zhan M; Zhang H; Wang QT; Sun SN; Guo XK; Yin H; Wei Y; Liu JO; Li SY; Li Y; He YW
Hepatology; 2021 Jan; 73(1):414-421. PubMed ID: 32299136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
